Elisa Petris
InvestorManaging Partner, Syncona Investment Management Limited at Syncona
About
Elisa Petris is a Managing Partner at Syncona Investment Management Limited and a member of the firm's founding team, with over a decade of experience building its portfolio of life science companies. She has helped establish companies including Quell, Blue Earth, Achilles, and Beacon, serving as Chief Business Officer at Beacon during its early period. Before Syncona she was a Senior Associate at Michel Dyens & Co. and worked on the Life Sciences team at L.E.K. Consulting; she holds a PhD in Molecular Biology from Imperial College London and an MBA from London Business School.
Invests in
BiotechHealthtechMedical Devices
Deals · 1
Neogene TherapeuticsBoard seat
via Syncona · filed Sep 2020 · $110M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Achilles TherapeuticsBeacon TherapeuticsBlue Earth DiagnosticsForcefield TherapeuticsQuell Therapeutics
Sources: the firm's website · SEC Form D filings.
Colleagues at Syncona
Frequently asked questions
- Who is Elisa Petris?
- Elisa Petris is a Managing Partner at Syncona Investment Management Limited and a member of the firm's founding team, with over a decade of experience building its portfolio of life science companies. She has helped establish companies including Quell, Blue Earth, Achilles, and Beacon, serving as Chief Business Officer at Beacon during its early period. Before Syncona she was a Senior Associate at Michel Dyens & Co. and worked on the Life Sciences team at L.E.K. Consulting; she holds a PhD in Molecular Biology from Imperial College London and an MBA from London Business School.
- Where does Elisa Petris work?
- Elisa Petris is Managing Partner, Syncona Investment Management Limited at Syncona.
- What does Elisa Petris invest in?
- Elisa Petris invests in Biotech, Healthtech, Medical Devices.
- What boards does Elisa Petris sit on?
- Elisa Petris holds tracked board seats at Achilles Therapeutics, Beacon Therapeutics, Blue Earth Diagnostics, Forcefield Therapeutics, Neogene Therapeutics, Neogene Therapeutics, Quell Therapeutics.